Market Overview
Sichuan Hebang Biotechnol (603077.SS) finished the 24‑hour trading window ending at 12:18 PM Central Europe unchanged, registering a flat 0 % move. The share is trading near CNY 2.12 on major exchanges, with a current supply of 8.8 bn shares and a market capitalisation of CNY 18.7 bn. Over the past 24 hours, the stock has traded approximately CNY 131.3 mn.
Since the close of the previous month, the company’s shares have declined by 7.86 %. The 200‑day simple moving average sits at CNY 2.34, signalling that the current price is below the long‑term trend. The 52‑week high of CNY 3.54 (03 /13 /2026) and the 52‑week low of CNY 2.07 (07 /13 /2026) underline the volatility that the stock has experienced this year.
Peer Performance
| Stock | Symbol | 24‑h Movement | Current Price | Market Cap (CNY bn) |
|---|---|---|---|---|
| Pantum | 002180.SZ | Flat 0 % | CNY 15.64 | 22.3 |
| Levima Advanced Materials | 003022.SZ | Flat 0 % | CNY 16.6 | 22.4 |
| Dongguan Dingtong Precisio | 688668.SS | Flat 0 % | CNY 160.04 | 22.3 |
| Vantone Neo Development Group | 600246.SS | Flat 0 % | CNY 11.59 | 22.4 |
| Western Region Gold | 601069.SS | Flat 0 % | CNY 24.38 | 22.4 |
Key ratios:
- Levima Advanced Materials – P/E 47
- Dongguan Dingtong Precisio – P/E 115.44
- Western Region Gold – P/E 24.96
Financing Activity on the STAR Market
The Shenzhen STAR Market saw a modest rise in leveraged financing during the day, with a particular influx of net purchases by institutional investors. Technology, machinery, and basic chemicals sectors attracted the most financing, reflecting a concentrated investment appetite in these growth areas. The sector‑wide trend suggests a cautious yet optimistic view of the market’s future trajectory.
Company Snapshot
Sichuan Hebang Biotechnol is a chemicals producer based in Leshan, China. The company’s portfolio includes soda ash (sodium carbonate), ammonium chloride, and other specialty chemicals, alongside condiment products. Listed on the Shanghai Stock Exchange since its IPO on 31 July 2012, the firm continues to expand its product range and market presence. More detailed information is available on the company’s website, www.hebang.cn .
Forward‑Looking Perspective
Despite a recent 7.86 % decline, Sichuan Hebang Biotechnol’s price remains comfortably below its 200‑day moving average, suggesting potential upside if the broader chemical sector recovers. The firm’s diversified product base and established distribution network position it well to capture demand shifts in both domestic and international markets. Investors should monitor the company’s earnings releases and any strategic initiatives aimed at expanding its specialty chemical offerings, as these developments could catalyse a rebound in share price.